Skip to content

SHIRE SERVICES

Inactive
Private limited companyKBO/BCE: BE 0898.258.897

Inactive since 23-04-2026; last annual accounts for financial year 2026. Dissolved and wound up in a single deed; no liquidator appointed; books and records kept in Opfikon-Glattpark Zurich.

SHIRE SERVICESInactive

Overview

Activity
“De vennootschap heeft tot voorwerp, in België en in het buitenland, uitsluitend in eigen…” (deed in Dutch)
From the articlesNo NACE code in the KBO yet
Size
€49.9mtotal assets 2026
Equity
€49.9m
Profit
€113,319
Net result -93%: 3-month year
Financial health
Inactive: no score
Structure
Parent
Takeda Pharmaceuticals International AG · 100%
Auditor: KPMG Réviseurs d'Entreprises
SignalsneutralLatest accounts filed on timeShow the evidence

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 08-04-2026, 206 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
206 days early
2025
115 days early
2024
84 days late
2023
22 days late
2022
88 days late
2021
453 days late
2020
89 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 59 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. End & cessationResignation: Paul De Proft (sole…
  2. Annual accounts filedfinancial year 2026 · full…
  3. Annual accounts filedfinancial year 2025 · full…

Key points

  • Risk: No longer active Inactive View
  • Result fell in 20263-month financial year ▼ 92.8% View
  • Controlled by Takeda Pharmaceuticals International AGultimately: SHIRE PLC 100% View
  • Positive: 5 profitable years in a rowprofit 2026: €113,319 5 years View

By topic

Financials

Financial year
2026
Total assets
€49.9m
Profit
€113,319
Solvency
100.0%
Turnover▼ 100%
Net result
20192023
Go to Financials

Board & ownership

Board
3 members
Parent
Takeda Pharmaceuticals International AG · 100%
Auditor
KPMG Réviseurs d'Entreprises
  • MILANO Vincent JamesManager
  • Laurent Gérard Jean-Marie HenauxManager
  • Paul Maria Cyriel De ProftManager
Go to Board & ownership

Timeline

Events
56
Since
2008
  1. 31-12-2025Liquidity more than 5 times
  2. 05-12-2025Reappointment: KPMG Bedrijfsrevisoren BV (statutory auditor)
  3. 23-10-2025Annual accounts filed
Go to Timeline

Company details

Legal form
Private limited company
Year ends
31-03
Peppol
Still in the Peppol directory
Go to Company details

Articles of association

Provisions read
1
Purpose
“De vennootschap heeft tot voorwerp, in België en in het buitenland, uitsluitend in eigen…” (deed in Dutch)
Go to Articles of association

Go further with this company

Investigating this company? Keep it with today's facts in a case file.